购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-14 (Compound 4) 是一款抑制羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的化学物质,其对白三烯 B3 与雌二醇的 IC50 值均不超过 1 μM 和 0.1 μM。此化合物主要用于研究肝病、代谢性疾病和心血管病,包括非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪肝炎 (NASH) 以及药物性肝损伤 (DILI)。
HSD17B13-IN-14 (Compound 4) 是一款抑制羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的化学物质,其对白三烯 B3 与雌二醇的 IC50 值均不超过 1 μM 和 0.1 μM。此化合物主要用于研究肝病、代谢性疾病和心血管病,包括非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪肝炎 (NASH) 以及药物性肝损伤 (DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-14 (Compound 4) acts as a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), achieving an IC 50 of ≤ 1 μM for leukotriene B3 and ≤ 0.1 μM for estradiol. This compound is utilized in studying various conditions, including liver diseases, metabolic disorders, and cardiovascular diseases like NAFLD or NASH, as well as drug-induced liver injury (DILI) [1]. |
分子量 | 425.89 |
分子式 | C21H16ClN3O3S |
CAS No. | 2758802-05-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容